🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the pharmacokinetics and safety fro...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-22
Trial ID
NCT02519452
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-15
Trial ID
NCT06418477
Treatments Being Tested
This is a Phase 3, randomized (study drug assigned by chance), open-label (...
Status
Active Not Recruiting
Location
Chru Jean Minjoz
Start Date
2019-10-17
Trial ID
NCT03993912
The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Status
Active Not Recruiting
Location
Transplant-nephrology department
Start Date
2025-11-01
Trial ID
NCT07274462
Treatments Being Tested
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Start Date
2019-01-03
Trial ID
NCT03829371
Treatments Being Tested
The purpose of this study is to compare the efficacy (rate of very good par...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-05-31
Trial ID
NCT03871829
This is a multicenter, multi-country, open-label, Phase 1b/2a dose-escalati...
Status
Active Not Recruiting
Location
Local Institution - 102
Start Date
2016-10-14
Trial ID
NCT02773030
Single-Arm phase 2 trial evaluating efficacy of incorporating Daratumumab t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05054478
Treatments Being Tested
The purpose of this study is to evaluate the effects of the addition of dar...
Status
Completed
Location
Antwerpen
Start Date
2017-06-14
Trial ID
NCT03180736
Treatments Being Tested